Computational Drug Discovery in Patients with Endometriosis-Induced Infertility via Text Mining and Biomedical Databases
This study used text mining and bioinformatic tools to identify 49 existing drugs targeting 39 genes that may treat endometriosis-induced infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This preprint used text mining of published biomedical literature to derive differentially expressed genes associated with endometriosis and infertility, then intersected these sets to focus on EMT-induced infertility targets. Using GeneCodis for GO and KEGG pathway enrichment, STRING and Cytoscape/MCODE to identify a significant protein–protein interaction network module (with medium confidence), and DGIdb to map pathway-relevant genes to existing drug–gene interactions, the authors reported 550 common EMT/infertility genes and 39 potentially targetable genes linked to 49 drugs not previously used for EMT-induced infertility. A stated limitation is that the work is an in silico computational analysis based on publicly available databases and preprint-level methods, without experimental validation in patients or models. This paper is centrally about endometriosis—computational drug discovery for endometriosis-induced infertility using text mining and biomedical pathway/database analyses.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- Local Cytokines in Endometrial Tissue: The Role of Interleukin‐8 in the Pathogenesis of Endometriosis via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- New developments in the medical treatment of endometriosis via openalex
- Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes via openalex
- W2112946624 via openalex
- W2142663409 via openalex
- W2169413987 via openalex
- W2181337632 via openalex
- W2202954603 via openalex
- W2407612039 via openalex
- W2568498246 via openalex
- W2954544233 via openalex
- W2969603724 via openalex
- W99609265 via openalex
- W4294216483 via openalex
- W1925492557 via openalex
- W1988096090 via openalex
- W2061714289 via openalex
- W2082252587 via openalex
- W2096173332 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:38:44.028908+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00